Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Disposition to Issuer of 24,655 ABUS shares, $123.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Arbutus Biopharma Corp (ABUS) | Disposition to Issuer | 24,655 | $123.3K |
| Sep 24, 2026 | Arbutus Biopharma Corp (ABUS) | Exercise/Conversion | 116,408 | $372.5K |
| Feb 3, 2026 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 28,000 | n/a |
| Mar 20, 2025 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 310,422 | n/a |
| Oct 17, 2024 | Eloxx Pharmaceuticals, Inc. (ELOX) | Grant/Award | 12,000 | n/a |
| Jan 26, 2024 | Eloxx Pharmaceuticals, Inc. (ELOX) | Grant/Award | 7,500 | n/a |